Cost of intensive therapy.
نویسندگان
چکیده
منابع مشابه
Intensive Therapy
Of note in this volume is the fact that it is dedicated to the memory of Alfred Gilman. He, along with Louis S. Goodman, wrote the first two editions of this text, and he served as an editor until his death in 1984. He will be missed by all those who knew him. Despite Dr. Gilman's untimely death and the addition of two new editors, Theodore W. Rall and Ferid Murad, the book remains unchanged in...
متن کاملImpact of pharmacist’s interventions on cost of drug therapy in intensive care unit
UNLABELLED Pharmacist participation in patient care team has been shown to reduce incidence of adverse drug events, and overall drug costs. However, impact of pharmacist participation in the multidisciplinary intensive care team on cost saving and cost avoidance has little been studied in Thailand. OBJECTIVE To describe the characteristics of the interventions and to determine pharmacist's in...
متن کاملCost of intensive care in India
Critical care is often described as expensive care. However, standardized methodology that would enable determination and international comparisons of cost is currently lacking. This article attempts to review this important issue and develop a framework through which cost of critical care in India could be analyzed.
متن کاملCost-effectiveness of continuous glucose monitoring and intensive insulin therapy for type 1 diabetes
BACKGROUND Our objective was to determine the cost-effectiveness of Continuous Glucose Monitoring (CGM) technology with intensive insulin therapy compared to self-monitoring of blood glucose (SMBG) in adults with type 1 diabetes in the United States. METHODS A Markov cohort analysis was used to model the long-term disease progression of 12 different diabetes disease states, using a cycle leng...
متن کاملCost-effectiveness of postremission intensive therapy in patients with acute leukemia.
BACKGROUND We assessed the cost-effectiveness of high-dose arabinoside (HiDAC)-based and allogeneic stem-cell transplantation (alloSCT)-based therapy in patients with acute leukemia. PATIENTS AND METHODS We analyzed the outcome, cost and cost-effectiveness of 106 patients treated from January 1994 to January 2002 [94 acute myelogenous leukemia (AML)/12 acute lymphoblastic leukemia (ALL)]. For...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Anaesthesia
سال: 1991
ISSN: 0003-2409,1365-2044
DOI: 10.1111/j.1365-2044.1991.tb09648.x